ADMA Biologics
ADMA
#2669
Rank
C$7.44 B
Marketcap
$31.48
Share price
14.71%
Change (1 day)
505.10%
Change (1 year)

P/E ratio for ADMA Biologics (ADMA)

P/E ratio as of November 2024 (TTM): -113

According to ADMA Biologics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -113.1. At the end of 2022 the company had a P/E ratio of -11.4.

P/E ratio history for ADMA Biologics from 2013 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-11.4328.95%
2021-2.6620.06%
2020-2.22-50.14%
2019-4.44171.5%
2018-1.64-1.25%
2017-1.66-47.55%
2016-3.16-31.86%
2015-4.64-24.85%
2014-6.1788.3%
2013-3.28

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-1.24-98.90%๐Ÿ‡บ๐Ÿ‡ธ USA
67.3-159.52%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.9455-99.16%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.